• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒利用宿主脂质为自身谋利。

Hepatitis C Virus Uses Host Lipids to Its Own Advantage.

作者信息

Sidorkiewicz Malgorzata

机构信息

Department of Medical Biochemistry, Faculty of Health Sciences, Medical University of Lodz, 90-419 Lodz, Poland.

出版信息

Metabolites. 2021 Apr 27;11(5):273. doi: 10.3390/metabo11050273.

DOI:10.3390/metabo11050273
PMID:33925362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145847/
Abstract

Lipids and lipoproteins constitute indispensable components for living not only for humans. In the case of hepatitis C virus (HCV), the option of using the products of our lipid metabolism is "to be, or not to be". On the other hand, HCV infection, which is the main cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma, exerts a profound influence on lipid and lipoprotein metabolism of the host. The consequences of this alternation are frequently observed as hypolipidemia and hepatic steatosis in chronic hepatitis C (CHC) patients. The clinical relevance of these changes reflects the fact that lipids and lipoprotein play a crucial role in all steps of the life cycle of HCV. The virus circulates in the bloodstream as a highly lipidated lipo-viral particle (LVP) that defines HCV hepatotropism. Thus, strict relationships between lipids/lipoproteins and HCV are indispensable for the mechanism of viral entry into hepatocytes, viral replication, viral particles assembly and secretion. The purpose of this review is to summarize the tricks thanks to which HCV utilizes host lipid metabolism to its own advantage.

摘要

脂质和脂蛋白不仅是人类生存不可或缺的组成部分。就丙型肝炎病毒(HCV)而言,利用我们脂质代谢产物的选择是“生存还是毁灭”。另一方面,作为慢性肝炎、肝硬化和肝细胞癌的主要病因,HCV感染对宿主的脂质和脂蛋白代谢产生深远影响。这种改变的后果在慢性丙型肝炎(CHC)患者中经常表现为低脂血症和肝脂肪变性。这些变化的临床相关性反映了脂质和脂蛋白在HCV生命周期的所有阶段都起着关键作用这一事实。该病毒以高度脂化的脂病毒颗粒(LVP)形式在血液中循环,这决定了HCV的嗜肝性。因此,脂质/脂蛋白与HCV之间的严格关系对于病毒进入肝细胞、病毒复制、病毒颗粒组装和分泌机制而言不可或缺。本综述的目的是总结HCV利用宿主脂质代谢为自身谋利的诀窍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/0efab5e75022/metabolites-11-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/ca92d65aa7d1/metabolites-11-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/003564508549/metabolites-11-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/0efab5e75022/metabolites-11-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/ca92d65aa7d1/metabolites-11-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/003564508549/metabolites-11-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a1/8145847/0efab5e75022/metabolites-11-00273-g003.jpg

相似文献

1
Hepatitis C Virus Uses Host Lipids to Its Own Advantage.丙型肝炎病毒利用宿主脂质为自身谋利。
Metabolites. 2021 Apr 27;11(5):273. doi: 10.3390/metabo11050273.
2
Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.脂质:丙型肝炎病毒进入的关键和抗病毒策略的潜在靶点。
Biochimie. 2013 Jan;95(1):96-102. doi: 10.1016/j.biochi.2012.07.016. Epub 2012 Aug 1.
3
Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.丙型肝炎病毒与脂质代谢在病毒进入和组装过程中的相互作用。
Biochimie. 2017 Oct;141:62-69. doi: 10.1016/j.biochi.2017.06.009. Epub 2017 Jun 16.
4
Lipids and HCV.脂质与 HCV。
Semin Immunopathol. 2013 Jan;35(1):87-100. doi: 10.1007/s00281-012-0356-2. Epub 2012 Oct 31.
5
Chronic hepatitis C virus infection and lipoprotein metabolism.慢性丙型肝炎病毒感染与脂蛋白代谢
World J Gastroenterol. 2015 Sep 28;21(36):10299-313. doi: 10.3748/wjg.v21.i36.10299.
6
HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit.HCV 在脂滴处稍作停留:在离开前给脂滴补充脂质并穿上脂蛋白外衣。
Cells. 2019 Mar 12;8(3):233. doi: 10.3390/cells8030233.
7
The Role of Cytosolic Lipid Droplets in Hepatitis C Virus Replication, Assembly, and Release.细胞质脂滴在丙型肝炎病毒复制、组装和释放中的作用。
Biomed Res Int. 2023 Apr 14;2023:5156601. doi: 10.1155/2023/5156601. eCollection 2023.
8
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.丙型肝炎病毒的细胞进入:脂蛋白和细胞受体的作用
J Gen Virol. 2009 May;90(Pt 5):1055-1070. doi: 10.1099/vir.0.008300-0. Epub 2009 Mar 4.
9
Hepatitis C virus hijacks host lipid metabolism.丙型肝炎病毒劫持宿主脂质代谢。
Trends Endocrinol Metab. 2010 Jan;21(1):33-40. doi: 10.1016/j.tem.2009.07.005. Epub 2009 Oct 23.
10
TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.TM6SF2 促进感染肝细胞中丙型肝炎病毒的脂化和分泌。
Gastroenterology. 2018 Dec;155(6):1923-1935.e8. doi: 10.1053/j.gastro.2018.08.027. Epub 2018 Aug 23.

引用本文的文献

1
The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis.丙型肝炎病毒依赖的对Nrf1/ARE介导的基因表达的抑制作用有利于病毒形态发生。
Viruses. 2025 Jul 28;17(8):1052. doi: 10.3390/v17081052.
2
Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design.丙型肝炎病毒感染中的广泛中和抗体特征及其对疫苗设计的意义。
Vaccines (Basel). 2025 Jun 6;13(6):612. doi: 10.3390/vaccines13060612.
3
Hypoxia-inducible factor 2 triggers the production of highly infectious native-like hepatitis C virus particles.

本文引用的文献

1
Epidemiology of hepatitis C virus infection.丙型肝炎病毒感染的流行病学
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101596. doi: 10.1016/j.clinre.2020.101596. Epub 2021 Feb 17.
2
HCV Interplay with Lipoproteins: Inside or Outside the Cells?HCV 与脂蛋白的相互作用:在细胞内还是细胞外?
Viruses. 2020 Apr 12;12(4):434. doi: 10.3390/v12040434.
3
Hepatitis C Virus Translation Regulation.丙型肝炎病毒翻译调控。
缺氧诱导因子2触发高传染性的天然样丙型肝炎病毒颗粒的产生。
Cell Mol Life Sci. 2025 Jun 19;82(1):241. doi: 10.1007/s00018-025-05739-0.
4
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.丙型肝炎病毒4型病毒样颗粒(VLPs)的研发:埃及疫苗研发的新方法
BMC Biotechnol. 2025 Jan 18;25(1):8. doi: 10.1186/s12896-024-00935-5.
5
Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance.血清磷酯酰胆碱 32:0 作为丙型肝炎病毒清除前后肝硬变的生物标志物。
Int J Mol Sci. 2024 Jul 26;25(15):8161. doi: 10.3390/ijms25158161.
6
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.丙型肝炎病毒的当代见解:全面综述
Microorganisms. 2024 May 21;12(6):1035. doi: 10.3390/microorganisms12061035.
7
Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance.丙型肝炎清除后溶血磷脂酰胆碱水平升高。
Int J Mol Sci. 2024 Jan 18;25(2):1198. doi: 10.3390/ijms25021198.
8
Mendelian randomization analysis to elucidate the causal relationship between small molecule metabolites and ovarian cancer risk.孟德尔随机化分析以阐明小分子代谢物与卵巢癌风险之间的因果关系。
Front Oncol. 2023 Nov 28;13:1291033. doi: 10.3389/fonc.2023.1291033. eCollection 2023.
9
Is It Ever Wise to Edit Wild-Type Alleles? Engineered CRISPR Alleles Versus Millions of Years of Human Evolution.编辑野生型等位基因明智吗?与数百万年人类进化相比,工程化的 CRISPR 等位基因。
Arterioscler Thromb Vasc Biol. 2024 Feb;44(2):328-333. doi: 10.1161/ATVBAHA.123.318069. Epub 2023 Dec 7.
10
Can iron chelators ameliorate viral infections?铁螯合剂可以改善病毒感染吗?
Biometals. 2024 Apr;37(2):289-304. doi: 10.1007/s10534-023-00558-x. Epub 2023 Nov 29.
Int J Mol Sci. 2020 Mar 27;21(7):2328. doi: 10.3390/ijms21072328.
4
Hepatitis C virus internalization.丙型肝炎病毒内化
Virologie (Montrouge). 2013 Dec 1;17(6):401-413. doi: 10.1684/vir.2013.0542.
5
Hepatitis C.丙型肝炎。
Lancet. 2019 Oct 19;394(10207):1451-1466. doi: 10.1016/S0140-6736(19)32320-7.
6
Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle.Nir2 是 VAPs 的效应因子,对于丙型肝炎病毒的有效复制和病毒复制细胞器中磷脂酰肌醇 4-磷酸的富集是必要的。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.00742-19. Print 2019 Nov 15.
7
Epidemiological and etiological variations in hepatocellular carcinoma.肝细胞癌的流行病学和病因学变化。
Infection. 2020 Feb;48(1):7-17. doi: 10.1007/s15010-019-01345-y. Epub 2019 Jul 25.
8
Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.通过创建一个靠近脂滴的膜复制隔室来实现丙型肝炎病毒复制周期的时空调控。
Cell Rep. 2019 Jun 18;27(12):3602-3617.e5. doi: 10.1016/j.celrep.2019.05.063.
9
The Role of ApoE in HCV Infection and Comorbidity.载脂蛋白 E 在 HCV 感染和合并症中的作用。
Int J Mol Sci. 2019 Apr 25;20(8):2037. doi: 10.3390/ijms20082037.
10
miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5' terminus.miR-122 和 Ago 与 HCV 基因组的相互作用改变了病毒 5' 末端的结构。
Nucleic Acids Res. 2019 Jun 4;47(10):5307-5324. doi: 10.1093/nar/gkz194.